2014 Q1 Form 10-K Financial Statement
#000114420414019382 Filed on March 31, 2014
Income Statement
Concept | 2014 Q1 | 2013 Q4 | 2012 Q4 |
---|---|---|---|
Revenue | $1.062M | $880.0K | $600.0K |
YoY Change | 186.05% | 46.67% | 1400.0% |
Cost Of Revenue | $662.5K | $840.0K | $60.00K |
YoY Change | 161.34% | 1300.0% | 500.0% |
Gross Profit | $399.6K | $40.00K | $550.0K |
YoY Change | 239.19% | -92.73% | 2650.0% |
Gross Profit Margin | 37.62% | 4.55% | 91.67% |
Selling, General & Admin | $1.081M | $1.010M | $680.0K |
YoY Change | 76.22% | 48.53% | 36.0% |
% of Gross Profit | 270.38% | 2525.0% | 123.64% |
Research & Development | $236.8K | $30.00K | $680.0K |
YoY Change | -66.37% | -95.59% | 38.78% |
% of Gross Profit | 59.25% | 75.0% | 123.64% |
Depreciation & Amortization | $20.00K | $10.00K | $20.00K |
YoY Change | 100.0% | -50.0% | -300.0% |
% of Gross Profit | 5.0% | 25.0% | 3.64% |
Operating Expenses | $1.554M | $1.040M | $1.360M |
YoY Change | 0.89% | -23.53% | 37.37% |
Operating Profit | -$1.154M | -$1.000M | -$810.0K |
YoY Change | -18.85% | 23.46% | -16.49% |
Interest Expense | -$137.1K | -$120.0K | -$120.0K |
YoY Change | -33.68% | 0.0% | -47.83% |
% of Operating Profit | |||
Other Income/Expense, Net | $179.1K | ||
YoY Change | -186.65% | ||
Pretax Income | -$975.1K | -$1.130M | -$930.0K |
YoY Change | -40.14% | 21.51% | -22.5% |
Income Tax | -$460.0K | -$390.0K | |
% Of Pretax Income | |||
Net Earnings | -$975.1K | -$670.0K | -$540.0K |
YoY Change | -40.14% | 24.07% | -55.0% |
Net Earnings / Revenue | -91.8% | -76.14% | -90.0% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$83.83K | -$67.88K | -$60.34K |
COMMON SHARES | |||
Basic Shares Outstanding | 298.6M shares | 245.1M shares | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2014 Q1 | 2013 Q4 | 2012 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $11.20M | $2.200M | $1.700M |
YoY Change | 700.0% | 29.41% | 41.67% |
Cash & Equivalents | $6.416M | $2.183M | $1.729M |
Short-Term Investments | $4.700M | ||
Other Short-Term Assets | $200.0K | $600.0K | $500.0K |
YoY Change | 100.0% | 20.0% | |
Inventory | $146.5K | $245.6K | $682.4K |
Prepaid Expenses | |||
Receivables | $300.0K | $500.0K | $100.0K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $11.83M | $3.487M | $2.940M |
YoY Change | 455.46% | 18.62% | 73.17% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $155.4K | $144.4K | $145.6K |
YoY Change | 11.19% | -0.83% | -6.11% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $409.7K | $414.4K | $254.2K |
YoY Change | 59.07% | 63.0% | -5.84% |
Total Long-Term Assets | $565.1K | $558.8K | $399.8K |
YoY Change | 42.23% | 39.75% | -5.94% |
TOTAL ASSETS | |||
Total Short-Term Assets | $11.83M | $3.487M | $2.940M |
Total Long-Term Assets | $565.1K | $558.8K | $399.8K |
Total Assets | $12.39M | $4.046M | $3.339M |
YoY Change | 390.48% | 21.15% | 57.33% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $527.6K | $786.5K | $800.7K |
YoY Change | -25.13% | -1.77% | 18.59% |
Accrued Expenses | $400.0K | $400.0K | $300.0K |
YoY Change | 33.33% | 33.33% | -50.0% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $1.700M | $1.600M | $900.0K |
YoY Change | 77.78% | 200.0% | |
Total Short-Term Liabilities | $3.299M | $3.065M | $2.077M |
YoY Change | 232.05% | 47.58% | 35.92% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $3.299M | $3.065M | $2.077M |
Total Long-Term Liabilities | $0.00 | $0.00 | |
Total Liabilities | $3.300M | $3.065M | $2.077M |
YoY Change | 232.18% | 47.58% | 15.11% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$105.8M | ||
YoY Change | |||
Common Stock | $299.0K | $10.05K | $215.0K |
YoY Change | 30.61% | -95.32% | 21.02% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$7.259M | -$14.27M | -$11.63M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $12.39M | $4.046M | $3.339M |
YoY Change | 390.48% | 21.15% | 57.33% |
Cashflow Statement
Concept | 2014 Q1 | 2013 Q4 | 2012 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$975.1K | -$670.0K | -$540.0K |
YoY Change | -40.14% | 24.07% | -55.0% |
Depreciation, Depletion And Amortization | $20.00K | $10.00K | $20.00K |
YoY Change | 100.0% | -50.0% | -300.0% |
Cash From Operating Activities | -$800.1K | -$1.100M | -$770.0K |
YoY Change | -1.16% | 42.86% | -30.63% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $21.37K | -$170.0K | -$20.00K |
YoY Change | 877.58% | 750.0% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$4.750M | $0.00 | |
YoY Change | |||
Cash From Investing Activities | -$4.771M | -$170.0K | -$20.00K |
YoY Change | 218148.44% | 750.0% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $9.451M | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $9.803M | 1.180M | 460.0K |
YoY Change | 2078.49% | 156.52% | |
NET CHANGE | |||
Cash From Operating Activities | -$800.1K | -1.100M | -770.0K |
Cash From Investing Activities | -$4.771M | -170.0K | -20.00K |
Cash From Financing Activities | $9.803M | 1.180M | 460.0K |
Net Change In Cash | $4.232M | -90.00K | -330.0K |
YoY Change | -1270.26% | -72.73% | -70.27% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$800.1K | -$1.100M | -$770.0K |
Capital Expenditures | $21.37K | -$170.0K | -$20.00K |
Free Cash Flow | -$821.5K | -$930.0K | -$750.0K |
YoY Change | 1.21% | 24.0% | -32.43% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2013 | ctso |
Abandoned Patents
AbandonedPatents
|
USD | |
CY2012 | ctso |
Abandoned Patents
AbandonedPatents
|
USD | |
ctso |
Abandoned Patents
AbandonedPatents
|
183556 | USD | |
CY2013Q4 | ctso |
Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
|
361700 | USD |
CY2012Q4 | ctso |
Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
|
349841 | USD |
CY2005 | ctso |
Adjustments To Additional Paid In Capital Equity Investments Transactions
AdjustmentsToAdditionalPaidInCapitalEquityInvestmentsTransactions
|
USD | |
CY2009 | ctso |
Adjustments To Additional Paid In Capital Warrants Modified
AdjustmentsToAdditionalPaidInCapitalWarrantsModified
|
14885 | USD |
CY2000 | ctso |
Capital Contributions
CapitalContributions
|
1382872 | USD |
CY2001 | ctso |
Capital Contributions
CapitalContributions
|
13411506 | USD |
CY2002 | ctso |
Capital Contributions
CapitalContributions
|
6739189 | USD |
CY2003 | ctso |
Capital Contributions
CapitalContributions
|
4067250 | USD |
CY2006 | ctso |
Adjustment To Additional Paid In Capital Merger Transaction
AdjustmentToAdditionalPaidInCapitalMergerTransaction
|
10000000 | USD |
CY1999 | ctso |
Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
|
1070740 | USD |
CY2000 | ctso |
Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
|
88363 | USD |
CY2001 | ctso |
Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
|
161073 | USD |
CY2002 | ctso |
Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
|
156073 | USD |
CY2003 | ctso |
Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
|
16624 | USD |
CY2013Q4 | ctso |
Aggregate Debt Or Equity Financing Amount
AggregateDebtOrEquityFinancingAmount
|
750000 | USD |
CY2013Q4 | ctso |
Agreement To Purchase Shares Value
AgreementToPurchaseSharesValue
|
8500000 | USD |
CY2013 | ctso |
Agreement To Purchase Shares Value During Period
AgreementToPurchaseSharesValueDuringPeriod
|
50000 | USD |
CY1999 | ctso |
Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
|
46772 | USD |
CY2000 | ctso |
Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
|
15667 | USD |
CY2001 | ctso |
Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
|
12499 | USD |
ctso |
Capital Contributions
CapitalContributions
|
1143487 | USD | |
CY1998 | ctso |
Capital Contributions
CapitalContributions
|
2518236 | USD |
CY1999 | ctso |
Capital Contributions
CapitalContributions
|
14407916 | USD |
CY2004 | ctso |
Capital Contributions
CapitalContributions
|
512555 | USD |
CY2005 | ctso |
Capital Contributions
CapitalContributions
|
92287 | USD |
CY2013 | ctso |
Change In Fair Value Of Management Units
ChangeInFairValueOfManagementUnits
|
USD | |
CY2012 | ctso |
Change In Fair Value Of Management Units
ChangeInFairValueOfManagementUnits
|
USD | |
ctso |
Change In Fair Value Of Management Units
ChangeInFairValueOfManagementUnits
|
278087 | USD | |
CY2003 | ctso |
Changes In Fair Value Of Noncontrolling Interests
ChangesInFairValueOfNoncontrollingInterests
|
2952474 | USD |
CY2004 | ctso |
Changes In Fair Value Of Noncontrolling Interests
ChangesInFairValueOfNoncontrollingInterests
|
-2396291 | USD |
CY2005 | ctso |
Changes In Fair Value Of Noncontrolling Interests
ChangesInFairValueOfNoncontrollingInterests
|
-14551 | USD |
CY2013 | ctso |
Common Stock Issued As Inducement To Convert Convertible Notes Payable And Accrued Interest
CommonStockIssuedAsInducementToConvertConvertibleNotesPayableAndAccruedInterest
|
USD | |
CY2012 | ctso |
Common Stock Issued As Inducement To Convert Convertible Notes Payable And Accrued Interest
CommonStockIssuedAsInducementToConvertConvertibleNotesPayableAndAccruedInterest
|
USD | |
ctso |
Common Stock Issued As Inducement To Convert Convertible Notes Payable And Accrued Interest
CommonStockIssuedAsInducementToConvertConvertibleNotesPayableAndAccruedInterest
|
3351961 | USD | |
ctso |
Common Stock Issued Value Subscriptions
CommonStockIssuedValueSubscriptions
|
440000 | USD | |
CY1998 | ctso |
Common Stock Issued Value Subscriptions
CommonStockIssuedValueSubscriptions
|
50000 | USD |
CY2000 | ctso |
Common Stock Issued Value Subscriptions
CommonStockIssuedValueSubscriptions
|
100000 | USD |
CY1998 | ctso |
Common Stock Options Granted Value
CommonStockOptionsGrantedValue
|
1671 | USD |
CY2002 | ctso |
Common Stock Options Granted Value
CommonStockOptionsGrantedValue
|
176250 | USD |
CY2003 | ctso |
Common Stock Options Granted Value
CommonStockOptionsGrantedValue
|
65681 | USD |
CY2001 | ctso |
Common Stock Options Granted Value Employee
CommonStockOptionsGrantedValueEmployee
|
2847 | USD |
CY2002 | ctso |
Common Stock Options Granted Value Employee
CommonStockOptionsGrantedValueEmployee
|
2847 | USD |
CY2013 | ctso |
Consulting Fees
ConsultingFees
|
USD | |
CY2012 | ctso |
Consulting Fees
ConsultingFees
|
USD | |
ctso |
Consulting Fees
ConsultingFees
|
237836 | USD | |
CY2013Q4 | ctso |
Convertible Notes Current Unamortized Discount
ConvertibleNotesCurrentUnamortizedDiscount
|
198644 | USD |
CY2012Q4 | ctso |
Convertible Notes Current Unamortized Discount
ConvertibleNotesCurrentUnamortizedDiscount
|
178775 | USD |
CY2013Q2 | ctso |
Debt Instrument Percent Of Principal Amount
DebtInstrumentPercentOfPrincipalAmount
|
0.5 | pure |
CY2013 | ctso |
Debt Discount
DebtDiscount
|
331117 | USD |
CY2012 | ctso |
Debt Discount
DebtDiscount
|
87400 | USD |
ctso |
Debt Discount
DebtDiscount
|
1975322 | USD | |
ctso |
Debt Instrument Maturity Period
DebtInstrumentMaturityPeriod
|
P1Y | ||
CY2013Q2 | ctso |
Debt Instrument Maturity Period
DebtInstrumentMaturityPeriod
|
P1Y | |
CY2013Q3 | ctso |
Debt Instrument Percent Of Principal Amount
DebtInstrumentPercentOfPrincipalAmount
|
0.5 | pure |
CY1999 | ctso |
Deferred Compensation Obligation
DeferredCompensationObligation
|
USD | |
CY2000 | ctso |
Deferred Compensation Obligation
DeferredCompensationObligation
|
USD | |
CY2013 | ctso |
Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
|
-2378919 | USD |
CY2009 | ctso |
Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
|
-586023 | USD |
CY2010 | ctso |
Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
|
-2008882 | USD |
CY2011 | ctso |
Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
|
-3015023 | USD |
CY2013 | ctso |
Issuance Of Common Stock In Exchange For Convertible Notes Shares
IssuanceOfCommonStockInExchangeForConvertibleNotesShares
|
1634615 | shares |
CY2013 | ctso |
Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
|
1226042 | USD |
CY2012 | ctso |
Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
|
798911 | USD |
CY2012 | ctso |
Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
|
-2493930 | USD |
CY2008 | ctso |
Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
|
-262717 | USD |
CY2002 | ctso |
Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
|
-1350828 | USD |
CY2003 | ctso |
Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
|
-281340 | USD |
CY2005 | ctso |
Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
|
51565 | USD |
CY2006 | ctso |
Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
|
113821100 | USD |
CY2011 | ctso |
Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
|
1515130 | USD |
CY2007 | ctso |
Issuance Of Common Stock Value Dividends And Interest
IssuanceOfCommonStockValueDividendsAndInterest
|
361496 | USD |
CY2005 | ctso |
Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
|
836319 | USD |
CY2006 | ctso |
Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
|
5878140 | USD |
CY2007 | ctso |
Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
|
23002 | USD |
CY2011 | ctso |
Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
|
5000 | USD |
CY2013 | ctso |
Management Units Issued
ManagementUnitsIssued
|
USD | |
CY2012 | ctso |
Management Units Issued
ManagementUnitsIssued
|
USD | |
ctso |
Management Units Issued
ManagementUnitsIssued
|
437206 | USD | |
CY2013 | ctso |
Member Units Issued
MemberUnitsIssued
|
USD | |
CY2012 | ctso |
Member Units Issued
MemberUnitsIssued
|
USD | |
CY2013Q4 | ctso |
Number Of Patents Issued
NumberOfPatentsIssued
|
32 | pure |
CY2013 | ctso |
Period In Which Certain Amount Of Stock Can Be Sold
PeriodInWhichCertainAmountOfStockCanBeSold
|
P2Y | |
CY2013 | ctso |
Period In Which Common Stock Can Be Sold
PeriodInWhichCommonStockCanBeSold
|
P32M | |
CY2013 | ctso |
Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
|
2395520 | USD |
CY2012 | ctso |
Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
|
2511412 | USD |
ctso |
Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
|
13317555 | USD | |
CY2013 | ctso |
Preferred Stock Additional Shares Available For Issuance
PreferredStockAdditionalSharesAvailableForIssuance
|
87800000 | shares |
CY2013Q4 | ctso |
Preferred Stock Value Not Included In Stockholders Equity
PreferredStockValueNotIncludedInStockholdersEquity
|
15246350 | USD |
CY2012Q4 | ctso |
Preferred Stock Value Not Included In Stockholders Equity
PreferredStockValueNotIncludedInStockholdersEquity
|
12887817 | USD |
CY2013 | ctso |
Proceeds From Sale Of Net Operating Loss Carryforwards
ProceedsFromSaleOfNetOperatingLossCarryforwards
|
458000 | USD |
CY2012Q4 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsWeightedAverageGrantDateFairValue
|
0.050 | |
CY2013 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
|
2235000 | shares |
CY2012 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
|
4640000 | shares |
CY2013Q4 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableAggregateIntrinsicValue
|
1194000 | USD |
CY2012 | ctso |
Proceeds From Sale Of Net Operating Loss Carryforwards
ProceedsFromSaleOfNetOperatingLossCarryforwards
|
392000 | USD |
CY2013 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Forfeited In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue
|
0.056 | |
CY2013 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsForfeituresInPeriod
|
2035000 | shares |
CY2013Q4 | ctso |
Share Based Compensation Arrangement By Sharebased Payment Award Nonvested Options Grant Date Fair Value
ShareBasedCompensationArrangementBySharebasedPaymentAwardNonvestedOptionsGrantDateFairValue
|
263650 | USD |
CY2013 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Granted In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantedInPeriodWeightedAverageGrantDateFairValue
|
0.035 | |
CY2013 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantsInPeriod
|
14076000 | shares |
CY2013Q4 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingNumber
|
13418000 | shares |
CY2012Q4 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingNumber
|
7394000 | shares |
CY2013 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsVestedInPeriod
|
6017000 | shares |
CY2013 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
0.048 | |
CY2013 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Non Vested Options Vested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonVestedOptionsVestedNumber
|
9544000 | shares |
CY2013Q4 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsWeightedAverageGrantDateFairValue
|
0.034 | |
CY2013 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Granted In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantedInPeriodWeightedAverageRemainingContractualTerm
|
P5Y6M | |
CY2012 | ctso |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Granted In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantedInPeriodWeightedAverageRemainingContractualTerm
|
P6Y10M24D | |
CY2013Q4 | ctso |
Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y1M6D | |
CY2012Q4 | ctso |
Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y1M6D | |
CY2011Q4 | ctso |
Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y2M12D | |
CY1999 | ctso |
Stock Issued During Period Stock And Warrants For Services Or Claims
StockIssuedDuringPeriodStockAndWarrantsForServicesOrClaims
|
468526 | USD |
CY2009 | ctso |
Stock Issued During Period Value Conversion Of Convertible Securities Preferred Stock
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesPreferredStock
|
-6704 | USD |
CY2006 | ctso |
Stock Issued During Period Value Merger
StockIssuedDuringPeriodValueMerger
|
USD | |
CY2006 | ctso |
Stock Issued During Period Value Merger Note Payable
StockIssuedDuringPeriodValueMergerNotePayable
|
10000000 | USD |
CY2008 | ctso |
Stock Issued During Period Value New Issues Preferred Stock
StockIssuedDuringPeriodValueNewIssuesPreferredStock
|
-364747 | USD |
CY2006 | ctso |
Stock Issued During Period Value New Issues Preferred Stock
StockIssuedDuringPeriodValueNewIssuesPreferredStock
|
53000000 | USD |
CY2013 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2013 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2013 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | |
CY2006 | ctso |
Stock Issued During Period Value Redemption Of Convertible Securities
StockIssuedDuringPeriodValueRedemptionOfConvertibleSecurities
|
10000000 | USD |
CY2013 | ctso |
Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
|
139526 | USD |
CY2012 | ctso |
Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
|
USD | |
CY2009 | ctso |
Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
|
USD | |
CY2011 | ctso |
Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
|
USD | |
CY2013 | ctso |
Supplemental Noncash Transactions
SupplementalNoncashTransactions
|
USD | |
CY2012 | ctso |
Supplemental Noncash Transactions
SupplementalNoncashTransactions
|
USD | |
ctso |
Supplemental Noncash Transactions
SupplementalNoncashTransactions
|
768063 | USD | |
CY2013 | ctso |
Technology And Content Expense
TechnologyAndContentExpense
|
USD | |
CY2012 | ctso |
Technology And Content Expense
TechnologyAndContentExpense
|
USD | |
ctso |
Technology And Content Expense
TechnologyAndContentExpense
|
4550000 | USD | |
ctso |
Technology Contributions
TechnologyContributions
|
4550000 | USD | |
ctso |
Warrant Exercise Price
WarrantExercisePrice
|
0.10 | ||
CY2013Q2 | ctso |
Warrant Exercise Price
WarrantExercisePrice
|
0.15 | |
CY2013 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2013 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-12-31 | |
CY2013 | dei |
Document Type
DocumentType
|
10-K | |
CY2013 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001175151 | |
CY2014Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
298568099 | shares |
CY2013 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2013 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
CY2013Q2 | dei |
Entity Public Float
EntityPublicFloat
|
27665000 | USD |
CY2013 | dei |
Entity Registrant Name
EntityRegistrantName
|
Cytosorbents Corp | |
CY2013 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2013 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2013 | dei |
Trading Symbol
TradingSymbol
|
ctso | |
CY2013Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
1148217 | USD |
CY2012Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
1150511 | USD |
CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
786517 | USD |
CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
800670 | USD |
CY2013Q4 | us-gaap |
Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
|
351435 | USD |
CY2012Q4 | us-gaap |
Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
|
364285 | USD |
CY2013Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
453017 | USD |
CY2012Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
51779 | USD |
CY2013Q4 | us-gaap |
Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
|
364599 | USD |
CY2012Q4 | us-gaap |
Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
|
177797 | USD |
CY2013Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2401354 | USD |
CY2012Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2369240 | USD |
CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-55987 | USD |
CY2012Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-12662 | USD |
CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
91343135 | USD |
CY2012Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
86903415 | USD |
CY2013 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
24459 | USD |
CY2012 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
25289 | USD |
us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
132150 | USD | |
CY2013 | us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
USD | |
CY2012 | us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
USD | |
us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
533648 | USD | |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
331117 | USD |
CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
87700 | USD |
CY2010 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
306805 | USD |
CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
1250000 | USD |
CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
456937 | USD |
CY2012 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
63127 | USD |
CY2006 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1433520 | USD |
CY2007 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
498955 | USD |
CY2008 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
363563 | USD |
CY2009 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
236705 | USD |
CY2010 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
149325 | USD |
CY2011 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
865535 | USD |
CY2006 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
-6205630 | USD |
CY2008 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
40354 | USD |
CY2013 | us-gaap |
Advertising Expense
AdvertisingExpense
|
269000 | USD |
CY2012 | us-gaap |
Advertising Expense
AdvertisingExpense
|
23000 | USD |
CY2013 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
456900 | USD |
CY2012 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
63100 | USD |
CY2013Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | USD |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1729344 | USD |
CY2012Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | USD |
CY2013 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
311248 | USD |
CY2012 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
471352 | USD |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
2776977 | USD | |
CY2013Q4 | us-gaap |
Assets
Assets
|
4045735 | USD |
CY2012Q4 | us-gaap |
Assets
Assets
|
3339408 | USD |
CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
3486967 | USD |
CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2939588 | USD |
CY2013Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
558768 | USD |
CY2012Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
399820 | USD |
CY2013 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>1. BASIS OF PRESENTATION</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The accompanying consolidated financial statements include the results of CytoSorbents Corporation (the "Parent"), CytoSorbents, Inc. its wholly-owned operating subsidiary (the "Subsidiary"), and CytoSorbents Europe GmbH, its wholly-owned European subsidiary (the "European Subsidiary"), collectively referred to as "the Company."</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has experienced negative cash flows from operations since inception and has a deficit accumulated during the development stage at December 31, 2013 of $105,805,775. The Company is not currently generating significant revenue and is dependent on the proceeds of present and future financings to fund its research, development and commercialization program. The Company believes that it currently has adequate funding for more than the next twelve months of operations, however, it may have to raise additional capital to fund future operations. Although the Company has historically been successful in raising additional capital through equity and debt financings, there can be no assurance that the Company will be successful in raising additional capital in the future or that it will be on favorable terms. Furthermore, if the Company is successful in raising the additional financing, there can be no assurance that the amount will be sufficient to complete the Company's plans. These matters raise substantial doubt about the Company's ability to continue as a going concern. These consolidated financial statements do not include any adjustments related to the outcome of this uncertainty.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The Company is a development stage company and has not yet generated significant revenues. Since inception, the Company's expenses relate primarily to research and development, organizational activities, clinical manufacturing, regulatory compliance and operational strategic planning. Although the Company has made advances on these matters, there can be no assurance that the Company will continue to be successful regarding these issues, nor can there be any assurance that the Company will successfully implement its long-term strategic plans.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The Company has developed an intellectual property portfolio, including 32 issued U.S. patents and multiple pending patents, covering materials, methods of production, systems incorporating the technology and multiple medical uses.</p> <!--EndFragment--></div> </div> | |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2183030 | USD |
CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1186653 | USD |
CY1997Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
USD | |
CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
453686 | USD |
CY2012 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
542691 | USD |
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
2183030 | USD | |
CY2013Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
26437617 | shares |
CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
800000000 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
800000000 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
251319547 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
214967503 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
251319547 | shares |
CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
214967503 | shares |
CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
251320 | USD |
CY2013 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
USD | |
CY2012 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
USD | |
us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
399395 | USD | |
CY2013Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
1644000 | USD |
CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
214968 | USD |
CY2013 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-4721120 | USD |
CY2012 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3676168 | USD |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-92544207 | USD | |
CY2013 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> <strong>Concentration of Credit Risk</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in; font-size-adjust: none; font-stretch: normal"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> The Company maintains cash balances, at times, with financial institutions in excess of amounts insured by the Federal Deposit Insurance Corporation. Management monitors the soundness of these institutions in an effort to minimize its collection risk of these balances.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> As of December 31, 2013, a U.S. Government agency accounted for approximately 66 percent of outstanding accounts receivable. At December 31, 2012, grant and accounts receivable consisted of direct hospital customers who in the aggregate represented 100% of outstanding accounts receivable, each of whom individually had more than 10 percent of outstanding accounts receivable. For the year ended December 31, 2013, approximately 62 percent of revenues were from two U.S. government agencies, and no other agency, distributor, or direct customer represented more than 10% of the Company's revenue. For the year ended December 31, 2012, approximately 81 percent of revenue was from a U.S. government grant agency.</p> <!--EndFragment--></div> </div> | |
CY2013 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
USD | |
CY2012 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
USD | |
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
559 | USD | |
CY2012Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
926000 | USD |
CY2013Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
1644356 | USD |
CY2012Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
926225 | USD |
CY2013 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
1911565 | USD |
CY2012 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
319298 | USD |
us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
2745436 | USD | |
CY2013 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
1226042 | USD |
CY2012 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
USD | |
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
13175491 | USD | |
CY2012 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
9739912 | shares |
CY2013Q2 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
8784000 | shares |
CY2013 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
160105 | USD |
CY2012 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
48912 | USD |
CY2013Q3 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.125 | |
CY2013 | us-gaap |
Depreciation
Depreciation
|
39891 | USD |
CY2012 | us-gaap |
Depreciation
Depreciation
|
29316 | USD |
us-gaap |
Depreciation
Depreciation
|
2460678 | USD | |
CY2013 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
64350 | USD |
CY2012 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
54606 | USD |
CY2013Q2 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.125 | |
CY2013Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
1511883 | USD |
CY2012Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
612300 | USD |
CY2013Q3 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
745000 | USD |
CY2013Q2 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
1098000 | USD |
us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.08 | pure | |
CY2013Q2 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.08 | pure |
CY2013Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
199000 | USD |
CY2012Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
179000 | USD |
CY2013Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
272359 | USD |
CY2012Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
USD | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2568371 | USD | |
CY2013Q4 | us-gaap |
Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
|
105805775 | USD |
CY2012Q4 | us-gaap |
Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
|
98732460 | USD |
CY2013 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
USD | |
CY2012 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
USD | |
CY2006 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
USD | |
CY2008 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
USD | |
CY2009 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
USD | |
CY2010 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
USD | |
CY2011 | us-gaap |
Dividends Preferred Stock Stock
DividendsPreferredStockStock
|
USD | |
CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | |
CY2012 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
25000 | USD |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
25000 | USD |
CY2013 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
pure | |
CY2012 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
pure | |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.34 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
-0.34 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.298 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.288 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
|
0.004 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
|
0.008 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.029 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0.044 | pure |
CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0.009 | pure |
CY2012 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
pure | |
CY2013 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-43325 | USD |
CY2012 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-12662 | USD |
us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-55987 | USD | |
CY2013Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
86000 | USD |
CY2013 | us-gaap |
Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
|
0.10 | |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
25000 | USD |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
25000 | USD |
CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
25000 | USD |
CY2013 | us-gaap |
Freight Costs
FreightCosts
|
33000 | USD |
CY2012 | us-gaap |
Freight Costs
FreightCosts
|
65000 | USD |
CY2013 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
USD | |
CY2012 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
USD | |
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
21663 | USD | |
CY2013 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
USD | |
CY2012 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
USD | |
us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
216617 | USD | |
CY2013 | us-gaap |
Gross Profit
GrossProfit
|
511102 | USD |
CY2012 | us-gaap |
Gross Profit
GrossProfit
|
1023638 | USD |
us-gaap |
Gross Profit
GrossProfit
|
2056690 | USD | |
CY2012 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
432365 | USD |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
876860 | USD | |
CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-458279 | USD |
CY2012 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-391756 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1397353 | USD | |
CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
245608 | USD |
CY2012Q4 | us-gaap |
Inventory Net
InventoryNet
|
682372 | USD |
CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-5136074 | USD |
CY2012 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-4055262 | USD |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-93885573 | USD | |
CY2013 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
118748 | USD |
CY2012 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
147948 | USD |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
3224552 | USD | |
CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
401238 | USD |
CY2012 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
15701 | USD |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
453017 | USD | |
CY2013 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
272359 | USD |
CY2012 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
USD | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
272359 | USD | |
CY2013 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
USD | |
CY2012 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
USD | |
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
1823103 | USD | |
CY2013 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-436764 | USD |
CY2012 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
251350 | USD |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
245608 | USD | |
CY2013 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
6942 | USD |
CY2012 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-9441 | USD |
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
53895 | USD | |
CY2013 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
129219 | USD |
CY2012 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
235762 | USD |
CY2013 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-422843 | USD |
CY2012 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-564428 | USD |
us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-7724393 | USD | |
CY2013 | us-gaap |
Interest Paid
InterestPaid
|
USD | |
CY2012 | us-gaap |
Interest Paid
InterestPaid
|
USD | |
us-gaap |
Interest Paid
InterestPaid
|
590189 | USD | |
CY2013Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
107098 | USD |
CY2012Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
438790 | USD |
CY2013Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
37982 | USD |
CY2012Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
48702 | USD |
CY2013Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
100528 | USD |
CY2012Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
194880 | USD |
CY2013 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
65468 | USD |
CY2012 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
USD | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
95468 | USD | |
CY2013 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
315000 | USD |
CY2012 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
334000 | USD |
CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
3064932 | USD |
CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
2076736 | USD |
CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4045735 | USD |
CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3339408 | USD |
CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3064932 | USD |
CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2076736 | USD |
CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4202687 | USD |
CY2012 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4210606 | USD |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
76657550 | USD | |
CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-216356 | USD |
CY2012 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-38806 | USD |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4735357 | USD | |
CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3489320 | USD |
CY2012 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3616447 | USD |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-69683176 | USD | |
CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4677795 | USD |
CY2012 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3663506 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-92488220 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-5256012 | USD | |
CY1998 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1867348 | USD |
CY1999 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10753871 | USD |
CY2000 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3066388 | USD |
CY2001 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15392618 | USD |
CY2002 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11871668 | USD |
CY2003 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6009283 | USD |
CY2004 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1096683 | USD |
CY2005 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3665596 | USD |
CY2006 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-76715800 | USD |
CY2007 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3350754 | USD |
CY2008 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3017890 | USD |
CY2009 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2736715 | USD |
CY2010 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2908865 | USD |
CY2011 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5481648 | USD |
CY2013 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-7073315 | USD |
CY2012 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-6174918 | USD |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-105805775 | USD | |
CY2013 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-422843 | USD |
CY2012 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-564428 | USD |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-7847608 | USD | |
CY2013 | us-gaap |
Operating Expenses
OperatingExpenses
|
5224333 | USD |
CY2012 | us-gaap |
Operating Expenses
OperatingExpenses
|
4514472 | USD |
us-gaap |
Operating Expenses
OperatingExpenses
|
88094655 | USD | |
CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4713231 | USD |
CY2012 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3490834 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-86037965 | USD | |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
178135 | USD |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
145735 | USD |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
|
16200 | USD |
CY2013Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
16200 | USD |
CY2013Q4 | us-gaap |
Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
|
432183 | USD |
CY2012Q4 | us-gaap |
Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
|
608429 | USD |
CY2013 | us-gaap |
Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
|
USD | |
CY2012 | us-gaap |
Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
|
USD | |
us-gaap |
Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
|
74938 | USD | |
CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
414375 | USD |
CY2012Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
254220 | USD |
CY2013 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-43325 | USD |
CY2012 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-12662 | USD |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-55987 | USD | |
CY2013 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-43325 | USD |
CY2012 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-12662 | USD |
CY2013 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-3300000 | USD |
CY2012 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-3100000 | USD |
CY2013Q4 | us-gaap |
Other Intangible Assets Net
OtherIntangibleAssetsNet
|
360481 | USD |
CY2012Q4 | us-gaap |
Other Intangible Assets Net
OtherIntangibleAssetsNet
|
207267 | USD |
CY2013 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
USD | |
CY2012 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
USD | |
us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
361496 | USD | |
CY2013 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
USD | |
CY2012 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
USD | |
us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
361495 | USD | |
CY2013 | us-gaap |
Other Operating Income
OtherOperatingIncome
|
USD | |
CY2012 | us-gaap |
Other Operating Income
OtherOperatingIncome
|
USD | |
us-gaap |
Other Operating Income
OtherOperatingIncome
|
6055483 | USD | |
CY2013 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
USD | |
CY2012 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
USD | |
us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
3147 | USD | |
CY2013 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
177672 | USD |
CY2012 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
18956 | USD |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
676186 | USD | |
CY2013 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
USD | |
CY2012 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
USD | |
us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
393607 | USD | |
us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
499395 | USD | |
CY2013 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
USD | |
CY2012 | us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
USD | |
us-gaap |
Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
|
393607 | USD | |
CY2013 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
USD | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.03 | |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.04 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
47923642 | shares |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
36667616 | shares |
CY2013 | us-gaap |
Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
|
USD | |
CY2012 | us-gaap |
Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
|
USD | |
us-gaap |
Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
|
1632168 | USD | |
CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
38684 | USD |
CY2012 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
19850 | USD |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2459494 | USD | |
CY2013Q4 | us-gaap |
Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
|
15600000 | shares |
CY2013 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
2395520 | USD |
CY2012 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
2511412 | USD |
us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
13317555 | USD | |
CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
1 | |
CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
100000000 | shares |
CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
1760 | USD |
CY2012Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
1594 | USD |
CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
605312 | USD |
CY2012Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
476093 | USD |
CY2013 | us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
2199967 | USD |
CY2012 | us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
3500001 | USD |
us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
52671768 | USD | |
CY2013 | us-gaap |
Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
|
USD | |
CY2012 | us-gaap |
Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
|
USD | |
us-gaap |
Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
|
9579040 | USD | |
CY2013 | us-gaap |
Proceeds From Other Debt
ProceedsFromOtherDebt
|
1843000 | USD |
CY2012 | us-gaap |
Proceeds From Other Debt
ProceedsFromOtherDebt
|
700000 | USD |
us-gaap |
Proceeds From Other Debt
ProceedsFromOtherDebt
|
13731881 | USD | |
CY2013 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
USD | |
CY2012 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
USD | |
CY2012 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
USD | |
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
32491 | USD | |
CY2013 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
20194 | USD |
CY2012 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
10605 | USD |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
35940 | USD | |
CY2013 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
139526 | USD |
CY2012 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
USD | |
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
139526 | USD | |
CY2013 | us-gaap |
Professional Fees
ProfessionalFees
|
908644 | USD |
CY2012 | us-gaap |
Professional Fees
ProfessionalFees
|
627245 | USD |
us-gaap |
Professional Fees
ProfessionalFees
|
9493779 | USD | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.11 | |
CY2008 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
CY2009 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
681558 | USD |
CY2010 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
1437814 | USD |
CY2013Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2545747 | USD |
CY2012Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2514840 | USD |
CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
144393 | USD |
CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
145600 | USD |
CY2012 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.15 | |
CY2011 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
187462 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
65468 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2299967 | USD |
CY2012 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3660153 | USD |
CY2006 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
7998850 | USD |
CY2013 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
USD | |
CY2012 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
USD | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
255882 | USD | |
CY2013 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1738938 | USD |
CY2012 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2532489 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
55668397 | USD | |
CY2013 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
1600880 | USD |
CY2012 | us-gaap |
Revenue From Grants
RevenueFromGrants
|
1191362 | USD |
us-gaap |
Revenue From Grants
RevenueFromGrants
|
3792687 | USD | |
CY2011Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
39833438 | shares |
CY2013 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
821787 | USD |
CY2012 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
151574 | USD |
us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
1009439 | USD | |
CY2013 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
2422667 | USD |
CY2012 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
1342936 | USD |
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
4802126 | USD | |
us-gaap |
Stock Issued1
StockIssued1
|
633133 | USD | |
CY2013 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
556737 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.20 | |
CY2012Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.23 | |
CY2011Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.39 | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.04 | |
CY2012 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
303039 | shares |
CY2013 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
20386 | USD |
CY2012 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
14484 | USD |
CY2006 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
USD | |
CY2013Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
53894 | USD |
CY2012Q4 | us-gaap |
Security Deposit
SecurityDeposit
|
46953 | USD |
CY2013 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2576751 | USD |
CY2012 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1354738 | USD |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
28987962 | USD | |
CY2013 | us-gaap |
Service Management Costs
ServiceManagementCosts
|
USD | |
CY2012 | us-gaap |
Service Management Costs
ServiceManagementCosts
|
USD | |
us-gaap |
Service Management Costs
ServiceManagementCosts
|
1334285 | USD | |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.28 | pure |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0189 | pure |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0075 | pure |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
34505642 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
28237 | shares |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
190783 | shares |
CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
14076000 | shares |
CY2012 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
1968000 | shares |
CY2012 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.04 | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
7.71 | |
CY2012 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
34.72 | |
CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.12 | |
CY2012 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.14 | |
CY2007 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
USD | |
CY2010 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
749999 | USD |
CY2011 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2643766 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
-100000 | USD |
CY2010 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
-49560 | USD |
CY2013 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
20194 | USD |
CY2012 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
10606 | USD |
CY2013Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
|
0.23 | |
CY2013 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
|
0.04 | |
CY2013 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
|
21.57 | |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14265547 | USD |
CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-11625145 | USD |
CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10090028 | USD |
CY1997Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
USD | |
CY1997Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
877475 | USD |
CY1998Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1580034 | USD |
CY1999Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
100548 | USD |
CY2000Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5340631 | USD |
CY2001Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2329208 | USD |
CY2002Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4374976 | USD |
CY2003Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3907307 | USD |
CY2004Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6967944 | USD |
CY2005Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9760207 | USD |
CY2006Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2363005 | USD |
CY2007Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-104296 | USD |
CY2008Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3345733 | USD |
CY2009Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5742027 | USD |
CY2010Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8065391 | USD |
CY2001 | us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
-1206730 | USD |
CY2002 | us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
-556047 | USD |
CY2003 | us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
-343737 | USD |
CY2004 | us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
-80218 | USD |
CY2005 | us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
-92287 | USD |
CY2013 | us-gaap |
Stock Issued1
StockIssued1
|
49647 | USD |
CY2012 | us-gaap |
Stock Issued1
StockIssued1
|
247536 | USD |
CY2011 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
5141 | USD |
CY2013 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
456937 | USD |
CY2012 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
63128 | USD |
us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
3025125 | USD | |
CY2013 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> <strong>Use of Estimates</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in; font-size-adjust: none; font-stretch: normal"> </p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities. Actual results could differ from these estimates. Significant estimates in these financials are the valuation of options granted and the valuation of preferred shares issued as stock dividends.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in; font-size-adjust: none; font-stretch: normal"> <strong> </strong></p> <!--EndFragment--></div> </div> | |
CY2013Q4 | us-gaap |
Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
|
171012 | USD |
CY2012Q4 | us-gaap |
Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
|
38788 | USD |
CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
236019072 | shares |
CY2012 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
198228289 | shares |